Literature DB >> 27789529

Molecular Pathways: The eIF4F Translation Initiation Complex-New Opportunities for Cancer Treatment.

Hélène Malka-Mahieu1,2,3, Michelle Newman1,2,3, Laurent Désaubry4,5, Caroline Robert6,7,8, Stéphan Vagner9,2,3,10,7.   

Abstract

The eIF4F complex regulates the cap-dependent mRNA translation process. It is becoming increasingly evident that aberrant activity of this complex is observed in many cancers, leading to the selective synthesis of proteins involved in tumor growth and metastasis. The selective translation of cellular mRNAs controlled by this complex also contributes to resistance to cancer treatments, and downregulation of the eIF4F complex components can restore sensitivity to various cancer therapies. Here, we review the contribution of the eIF4F complex to tumorigenesis, with a focus on its role in chemoresistance as well as the promising use of new small-molecule inhibitors of the complex, including flavaglines/rocaglates, hippuristanol, and pateamine A. Clin Cancer Res; 23(1); 21-25. ©2016 AACR. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27789529     DOI: 10.1158/1078-0432.CCR-14-2362

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  32 in total

1.  The mTORC1/4E-BP/eIF4E Axis Promotes Antibody Class Switching in B Lymphocytes.

Authors:  Honyin Chiu; Leandra V Jackson; Kwon Ik Oh; Annie Mai; Ze'ev A Ronai; Davide Ruggero; David A Fruman
Journal:  J Immunol       Date:  2018-12-10       Impact factor: 5.422

Review 2.  The PI3K Pathway in Human Disease.

Authors:  David A Fruman; Honyin Chiu; Benjamin D Hopkins; Shubha Bagrodia; Lewis C Cantley; Robert T Abraham
Journal:  Cell       Date:  2017-08-10       Impact factor: 41.582

3.  Translation regulation in skin cancer from a tRNA point of view.

Authors:  Katerina Grafanaki; Dimitrios Anastasakis; George Kyriakopoulos; Ilias Skeparnias; Sophia Georgiou; Constantinos Stathopoulos
Journal:  Epigenomics       Date:  2018-12-19       Impact factor: 4.778

4.  Targeting Protein Translation by Rocaglamide and Didesmethylrocaglamide to Treat MPNST and Other Sarcomas.

Authors:  Long-Sheng Chang; Janet L Oblinger; Sarah S Burns; Jie Huang; Larry W Anderson; Melinda G Hollingshead; Rulong Shen; Li Pan; Garima Agarwal; Yulin Ren; Ryan D Roberts; Barry R O'Keefe; A Douglas Kinghorn; Jerry M Collins
Journal:  Mol Cancer Ther       Date:  2019-12-17       Impact factor: 6.261

5.  Development of a novel peptide aptamer that interacts with the eIF4E capped-mRNA binding site using peptide epitope linker evolution (PELE).

Authors:  Yuri Frosi; Simon Ng; Yen-Chu Lin; Shimin Jiang; Siti Radhiah Ramlan; Dilraj Lama; Chandra S Verma; Ignacio Asial; Christopher J Brown
Journal:  RSC Chem Biol       Date:  2022-05-19

6.  A role for ceramide glycosylation in resistance to oxaliplatin in colorectal cancer.

Authors:  James P Madigan; Robert W Robey; Joanna E Poprawski; Huakang Huang; Christopher J Clarke; Michael M Gottesman; Myles C Cabot; Daniel W Rosenberg
Journal:  Exp Cell Res       Date:  2020-01-20       Impact factor: 3.905

7.  4Ei-10 interdiction of oncogenic cap-mediated translation as therapy for non-small cell lung cancer.

Authors:  Blake A Jacobson; Zeeshan Ahmad; Sierra Chen; Gabriella Waldusky; Maxwell Dillenburg; Emilia Stoian; Daniel A Cambron; Anil J Patel; Manish R Patel; Carston R Wagner; Robert A Kratzke
Journal:  Invest New Drugs       Date:  2020-11-23       Impact factor: 3.850

8.  P300/CBP inhibition sensitizes mantle cell lymphoma to PI3Kδ inhibitor idelalisib.

Authors:  Xiao-Ru Zhou; Xiao Li; Li-Ping Liao; Jie Han; Jing Huang; Jia-Cheng Li; Hong-Ru Tao; Shi-Jie Fan; Zhi-Feng Chen; Qi Li; Shi-Jie Chen; Hong Ding; Ya-Xi Yang; Bing Zhou; Hua-Liang Jiang; Kai-Xian Chen; Yuan-Yuan Zhang; Chuan-Xin Huang; Cheng Luo
Journal:  Acta Pharmacol Sin       Date:  2021-04-13       Impact factor: 6.150

Review 9.  Translational Regulation of Cancer Metastasis.

Authors:  Douglas S Micalizzi; Richard Y Ebright; Daniel A Haber; Shyamala Maheswaran
Journal:  Cancer Res       Date:  2021-01-21       Impact factor: 13.312

10.  eIF4A alleviates the translational repression mediated by classical secondary structures more than by G-quadruplexes.

Authors:  Joseph A Waldron; Farheen Raza; John Le Quesne
Journal:  Nucleic Acids Res       Date:  2018-04-06       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.